Article
Relationships of PROP Taste Phenotype, Taste Receptor Genotype, and Oral Nicotine Replacement Use.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco - 1 Sept 2015
Ahijevych Karen, Tepper Beverly J, Graham Margaret C, Holloman Christopher, Matcham William A
Abstract excerpt
INTRODUCTION: Recommended dosage of oral nicotine replacement therapy (NRT) product is often not achieved in smoking cessation attempts. n-6-propylthiouracil (PROP) bitter taste phenotype may be a potential risk factor for non-adherence to oral NRT products due to their bitter taste. There is limited literature on this phenotype in the context of smoking and none in relation to oral NRT pharmacotherapy. METHODS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
